Compare Intuitive Surgical, Inc. (ISRG) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Vale SA — how do they compare? Intuitive Surgical, Inc. trades at $424 (market cap $146.76B), while Vale SA trades at $13.63 (market cap $57.32B). The key difference: Intuitive Surgical, Inc. is far larger — about 2.6× Vale SA's market cap, and Vale SA pays a 8.87% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Vale SA for 109 Days on average.
| ISRG | VALE | |
|---|---|---|
Market Cap | $146.76B | $57.32B |
Volume | 2,529,814 | 27,996,846 |
Sector | Health | Basic Materials |
52-Week High | $592.85 | $17.82 |
52-Week Low | $332.02 | $10.75 |
Typical Hold Time | 84 Days | 109 Days |
Enterprise Value | $141.54B | $73.56B |
Dividend Yield | — | 8.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $423.96, up 2.28% with strong bullish momentum. The stock shows robust fundamentals with 2025 revenue reaching $10.06B and net income of $2.86B, maintaining 28.45% net margins. Recent quarters consistently beat EPS estimates, while technical indicators signal bullish moving averages. Analyst consensus remains strongly positive with 70% buy ratings and $480.78 price target, representing 13% upside potential.
ISRG's leadership in robotic surgery and expanding international presence in India and Japan provide growth catalysts, though China weakness and competitive pressures present risks. The stock's premium valuation (P/E 47.64) reflects high growth expectations, requiring continued execution. Current levels near resistance at $427 may test near-term momentum ahead of Q3 earnings.
VALE trades at $13.62, near recent lows, with a bearish technical outlook and mixed sentiment. The stock has missed earnings expectations in recent quarters, with Q3 2026 EPS expected at $0.4212. Revenue has declined from $43.8B in 2022 to $38.4B in 2025, though 2026 is projected at $41.2B. Net income margin compressed to 5.11% in 2025. Analyst consensus is a 'Hold' with a $16.21 price target, indicating modest upside potential from current levels.
VALE faces headwinds from cyclical commodity exposure and cost inflation, but its base metals segment shows growth. Investment appeal hinges on iron ore price stability and execution on cost controls. Risks include regulatory challenges in Brazil and volatile raw material markets. The stock offers a dividend yield but requires careful monitoring of earnings trajectory and macroeconomic factors affecting mining sectors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
